Nektar Therapeutics NKTR announced that the phase IIb REZOLVE-AD study evaluating its lead pipeline candidate, ...

The S&P 500 (^GSPC) flirted with all-time highs but ended the day nearly flat, just shy of its record level. Nvidia shares ...

Shares of BP rose Wednesday, lifted by a report that Shell was in talks to acquire it in what would mark a huge deal for the ...

Altimmune, Inc. (ALT) on Thursday said that its mid-stage study of Pemvidutide in metabolic dysfunction-associated ...

IonQ, Inc. (NYSE:IONQ) announced a new study in partnership with the University of Washington, which, using its Forte ...

Nigel Farage’s populist Reform UK would be the biggest party in parliament if the country held a general election today, ...

Investing.com -- Edgewise Therapeutics Inc (NASDAQ: EWTX) stock tumbled 7.2% after the company revealed that the U.S. Food and Drug Administration (FDA) deemed its CANYON trial data insufficient for ...

As an aging cohort of financial advisors prepares for retirement, firms are scrambling for next-gen talent. Yet a new study ...

Altimmune’s GLP-1/glucagon dual receptor agonist achieved a hit and a miss when it came to the dual goals of a phase 2 ...

Penumbra's AI-guided aspiration system and scalable platform uniquely position it as a leader in stroke and PE intervention.

Puma Biotechnology remains undervalued despite steady neratinib sales and a promising, though early-stage, pipeline. Learn ...

The Senate version of President Trump’s domestic policy bill will likely fall short of its ambitious promises for economic ...